ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (557)	6/10/1999 7:16:00 AM
From: Mike McFarland	Read Replies (2) of 4474

100-200, which takes us through most of 1997 B-S doesnt work that well for deeply out of the money options. Check back in 2002 or so and count your profits. ;-) Can anyone explain what the "venture rating" means for Lehman? BTW, it would be unwise to ignore the fact that 4 out of 4 analysts covering the company give it a perfect 1.0 rating. I am less enthusiastic about using Zack's-like numbers than you. That is, I feel that most biotech analysts are clowns with vested interests. Here is a post to read which has a copy of an email from Michael Gilman Message 1633545 BTW, the people at Ariad do read this site and derive a good deal of entertainment, as distinct from insight, from most of the posts. Warning....... scientists often write damn good science fiction. I feel that in a few years you will recall fondly those days when Ariad shares could be had for $5 and change. ARIAD Demonstrates Method For Orally Activated Protein Therapy December 2, 1997 09:45 AM (ARGENT) _____ I Hope this little exercise isn't pissing anybody off-- and it will get increasingly entertaining as we move through 1998, when the first posts from yours truly show up.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next